Technology News and Research

RSS

HIRC investigates the impact of infrastructure on pathogens and micro-organisms

The spread of swine flu and other infectious diseases could be dramatically reduced by revolutionising the way that the places we live in are designed and built.

17 Sep 2009

New intraoperative nerve integrity monitors from Medtronic

Medtronic (NYSE: MDT) recently announced the launch of the NIM-Response® 3.0 and NIM-Neuro® 3.0 intraoperative nerve integrity monitors designed for a variety of surgeons, including ear, nose, and throat (ENT); endocrine; general; and peripheral surgeons.

17 Sep 2009

Web-based healthcare IT ecosystem from CareCloud

Advancements in technology and universal acceptance of the Internet have paved the way for major improvements in the healthcare industry. According to a recent report released by PricewaterhouseCooper's Health Research Institute in August 2009, 1.2 trillion healthcare dollars are wasted each year, with two of the main culprits being administrative inefficiency and redundant care.

17 Sep 2009

Wireless sensor being studied at the Virginia Commonwealth University Medical Center

A wireless, credit-card-sized sensor that can detect whether health care workers have properly washed their hands upon entering a patient's room is being studied at the Virginia Commonwealth University Medical Center. The device could greatly reduce the number of hospital acquired infections nationwide since most are transmitted through contact due to poor hand-washing practice.

17 Sep 2009

DSM Biomedical develops cross-linkable UHMWPE platform

DSM Biomedical, a global leader in biomedical materials science, today announced a major step forward in the development of a new polyethylene polymer platform intended to improve the mechanical properties and long-term stability of hip and knee implants.

16 Sep 2009

Cryosurgery: Primary treatment option for prostate cancer

After years of innovation and intensive research, a team of Binghamton University (BU) researchers working with Cell Preservation Services, Inc., Owego, NY has broken extraordinary new ground in the recognition of cryosurgery as a primary treatment option for prostate cancer.

16 Sep 2009

BCA-member blood centers to use Haemonetics' suite of blood management software

Haemonetics Corporation announced today that it has signed a comprehensive software agreement with Blood Centers of America, Inc. ("BCA"), a cooperative of community blood centers.

16 Sep 2009

The first successful implantation of the GDS Accucinch System for mitral valve repair

Guided Delivery Systems, Inc. ("GDS") announced the first successful percutaneous implantation of the GDS Accucinch(R) System for mitral valve repair. The procedure was performed by Prof. Dr. med. Joachim Schofer of Medizinisches Versorgungszentrum, Hamburg University Cardiovascular Center in Hamburg, Germany. The GDS Accucinch System significantly reduced the patient's mitral regurgitation without requiring open heart surgery.

16 Sep 2009

OCLS' partnership with V&M Industries to market Microcyn-based skin and wound care products

Oculus Innovative Sciences, Inc., a biopharmaceutical company that develops, manufactures and markets a family of products based upon the Microcyn Technology platform, which is intended to treat infections in chronic and acute wounds, announced today it has entered into a new strategic partnership with V&M Industries, Inc. for non-exclusive rights to market Microcyn-based skin and wound care over-the-counter products in the United States and Canada while providing Oculus with a significant percentage of those revenues.

16 Sep 2009

FindPharma.com website for pharma professionals

Advanstar Communications announced today that it has launched FindPharma.com, a digital vertical search destination that will enable pharma professionals to find and filter relevant industry information, high quality suppliers and career assistance.

16 Sep 2009

i365’s EVault Plug-n-Protect chosen to back up critical patient and business data of Medical Business Service

i365, Inc., A Seagate Company (NASDAQ: STX), today announced that Medical Business Service, Inc. has moved to i365’s EVault Plug-n-Protect appliance for its complete data protection and recovery capabilities. Headquartered in Coral Gables, Florida, and the largest privately owned patient billing services company for hospital-based physicians, MBS required a reliable, efficient data protection solution that would allow it to back up critical patient and business data across the company’s thirteen branches.

16 Sep 2009

KemPharm announces nomination of its second pipeline candidate

KemPharm, Inc. today announced the nomination of its second pipeline candidate, KP201, based on its proprietary ligand activated therapy (LAT) platform. KP201 is a new chemical entity (NCE) for the treatment of pain with the possibility of reduced abuse potential. KP201 joins lead candidate KP106, which is a novel prodrug candidate in development for ADHD.

16 Sep 2009

Phytel's Proactive Patient Outreach solution to be deployed at the Mankato Clinic

Phytel, the industry leader in automated, physician-led health improvement, announced today that the Mankato Clinic, one of the largest physician-owned multispecialty groups in Minnesota, has agreed to deploy its Proactive Patient Outreach solution. The nearly century-old Mankato Clinic, which includes 110 providers in nine locations, selected Phytel to help reduce its no-show rate and to increase the provision of needed services to its patients.

16 Sep 2009

Children's Hospital enrolls patients for ExCell clinical study

Children's Hospital of Colorado and the Gamida Cell-Teva Joint Venture announced today that Children's Hospital is enrolling patients for the ExCell study. Children's Hospital is the 24th in a series of cord blood transplant sites worldwide, five of which are children's centers, participating in the study in the U.S., Spain, Italy, Hungary and Israel.

16 Sep 2009

Premion commences cancer treatment with Varian's RapidArc radiotherapy technology

Cancer patients in Australia have gained access to advanced RapidArc(R) radiotherapy treatments from Varian Medical Systems (NYSE: VAR) with its introduction by the leading radiation oncology provider in Queensland. Premion, which operates five cancer centers in Queensland, has treated more than a dozen prostate cancer patients to date with this fast, precise and efficient technique at its Chermside treatment center in Brisbane.

16 Sep 2009

Inovio’s novel platform for developing DNA based vaccines to be discussed at EmTech

Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, CEO, has been invited to present at EmTech, the Emerging Technologies Conference hosted by MIT and produced by MIT’s Technology Review magazine. The conference will take place September 22nd - 24th on the MIT campus in Cambridge, MA.

16 Sep 2009

CEL-SCI to commence its LEAPS-H1N1 clinical trial following FDA approval

CEL-SCI Corporation (NYSE Amex: CVM), a developer of vaccines and therapeutics for the prevention and treatment of infectious diseases and a late-stage oncology company, announced today that the U.S. Food and Drug Administration (FDA) has indicated that the Company can proceed with its first clinical trial to evaluate the effect of its investigational LEAPS-H1N1 treatment on the white blood cells of hospitalized H1N1 patients.

16 Sep 2009

Winner of LA's Best Award 2009

Los Angeles dentist, Dr. Sam Muslin, DDS, MAGD, has been awarded LA's Best Award (tm) 2009 for his leading edge, high quality dentistry.

16 Sep 2009

Perceptive Informatics utilizes Optasia's KneeAnalyzer software

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that it has enhanced its capabilities to provide medical imaging measurements for osteoarthritis clinical trials through an alliance with Optasia Medical, Inc.

From Parexel 16 Sep 2009

Savient updates on its Biologics License Application with the FDA for KRYSTEXXA

Savient Pharmaceuticals, Inc. (Nasdaq: SVNT) announced that on September 14, 2009, the Company completed a Type A meeting with the U.S. Food and Drug Administration (FDA) to discuss the Complete Response Letter (CRL) received by Savient on July 31, 2009 regarding the Company's Biologics License Application (BLA) for KRYSTEXXA(TM) (pegloticase) as a treatment for chronic gout in patients refractory to conventional therapy.

16 Sep 2009

Technology News and Research

HIRC investigates the impact of infrastructure on pathogens and micro-organisms

New intraoperative nerve integrity monitors from Medtronic

Web-based healthcare IT ecosystem from CareCloud

Wireless sensor being studied at the Virginia Commonwealth University Medical Center

DSM Biomedical develops cross-linkable UHMWPE platform

Cryosurgery: Primary treatment option for prostate cancer

BCA-member blood centers to use Haemonetics' suite of blood management software

The first successful implantation of the GDS Accucinch System for mitral valve repair

OCLS' partnership with V&M Industries to market Microcyn-based skin and wound care products

FindPharma.com website for pharma professionals

i365’s EVault Plug-n-Protect chosen to back up critical patient and business data of Medical Business Service

KemPharm announces nomination of its second pipeline candidate

Phytel's Proactive Patient Outreach solution to be deployed at the Mankato Clinic

Children's Hospital enrolls patients for ExCell clinical study

Premion commences cancer treatment with Varian's RapidArc radiotherapy technology

Inovio’s novel platform for developing DNA based vaccines to be discussed at EmTech

CEL-SCI to commence its LEAPS-H1N1 clinical trial following FDA approval

Winner of LA's Best Award 2009

Perceptive Informatics utilizes Optasia's KneeAnalyzer software

Savient updates on its Biologics License Application with the FDA for KRYSTEXXA

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News